公司资料
Calliditas Therapeutics AB 股价、新闻与催化剂
- 股票代码:
- CALT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Sweden
股价为何变动
Current closing-price context is not available for CALT.
公司概览
业务概览
Calliditas Therapeutics was a rare-disease and kidney-disease company focused on IgA nephropathy and related conditions before becoming a historical ticker. Its business reflected the value of specialty renal therapeutics in orphan disease.
所在地与行业分类
Calliditas was headquartered in Sweden and listed on NASDAQ. It sat in rare-disease biotechnology.
商业模式特征
The company depended on clinical success, label expansion, and commercial execution in a focused nephrology market. Investors watched regulatory progress and launch performance.
生物医药行业定位
Calliditas belongs to the historical rare-disease kidney bucket. It was a premium specialty biotech story before its strategic transition and legacy status.
未来催化剂
- Calliditas is now largely a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it like a live growth name.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。